^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BT1769

    i
    Other names: BT1769
    Associations

    News

    Trials
    Company:
    Bicycle Therap
    Drug class:
    MMP-14 inhibitor
    Related drugs:
    Associations

    News

    Trials
    over2years
    Comprehensive surfaceome profiling to identify and validate novel cell-surface targets in osteosarcoma. (PubMed, Mol Cancer Ther)
    The results showed BT1769 had encouraging anti-tumor activity, high affinity for its target and a favorable pharmacokinetic profile. This confirms the hypothesis that our approach identifies novel targets with significant therapeutic potential in osteosarcoma.
    Journal
    |
    CD276 (CD276 Molecule) • MMP14 (Matrix Metallopeptidase 14)
    |
    BT1769